0000899243-17-021630.txt : 20170907 0000899243-17-021630.hdr.sgml : 20170907 20170907203048 ACCESSION NUMBER: 0000899243-17-021630 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170906 FILED AS OF DATE: 20170907 DATE AS OF CHANGE: 20170907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scott Raymond W. CENTRAL INDEX KEY: 0001669477 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37918 FILM NUMBER: 171074952 MAIL ADDRESS: STREET 1: C/O IRHYTHM TECHNOLOGIES, INC. STREET 2: 650 TOWNSEND STREET, SUITE 380 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iRhythm Technologies, Inc. CENTRAL INDEX KEY: 0001388658 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 208149544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 650 TOWNSEND STREET STREET 2: SUITE 380 CITY: San Francisco STATE: CA ZIP: 94103 BUSINESS PHONE: 415-632-5700 MAIL ADDRESS: STREET 1: 650 TOWNSEND STREET STREET 2: SUITE 380 CITY: San Francisco STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: IRhythm Technologies, Inc. DATE OF NAME CHANGE: 20110429 FORMER COMPANY: FORMER CONFORMED NAME: IRhythm Technologies Inc DATE OF NAME CHANGE: 20070201 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-09-06 0 0001388658 iRhythm Technologies, Inc. IRTC 0001669477 Scott Raymond W. C/O IRHYTHM TECHNOLOGIES, INC. 650 TOWNSEND STREET, SUITE 500 SAN FRANCISCO CA 94103 1 0 0 0 Common Stock 2017-09-06 4 M 0 4661 8.18 A 4661 D Common Stock 2017-09-06 2017-09-06 4 S 0 4661 48.02 D 0 D Employee Stock Option (right to buy) 8.18 2017-09-06 4 M 0 4661 0.00 D 2025-12-15 Common Stock 4661 8088 D This transaction was executed in multiple trades at prices ranging from $48.00 to $48.15. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The option vested and the shares became exercisable according to the following schedule: I/I2 on February 1, 2016 and 1/12 of the shares on each full calendar month thereafter. /s/ Kristen Blumenthal, attorney in fact 2017-09-07